These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 32772877)

  • 1. Emerging Evidence of the Utility of Perfluorobutane-enhanced US as a Diagnostic Test for Hepatocellular Carcinoma.
    Kim TK; Jang HJ
    Radiology; 2020 Oct; 297(1):117-119. PubMed ID: 32772877
    [No Abstract]   [Full Text] [Related]  

  • 2. Contrast-enhanced US with Perfluorobutane for Hepatocellular Carcinoma Surveillance: A Multicenter Diagnostic Trial (SCAN).
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Lee SS; Han K; Nam CM; Park SH; Lee KH
    Radiology; 2019 Sep; 292(3):638-646. PubMed ID: 31287387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of Contrast-Enhanced Sonography With Perfluorobutane Microbubbles for Diagnosis of Recurrent Hepatocellular Carcinoma.
    Shagdarsuren B; Tamai H; Shingaki N; Mori Y; Maeshima S; Nuta J; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Jul; 35(7):1383-91. PubMed ID: 27208196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of hepatocellular carcinoma by contrast enhanced ultrasound: a novel technique.
    Paul SB; Jaganathan S; Hasan A; Dhingra R; Gamanagatti SR; Gupta AK; Acharya SK
    Trop Gastroenterol; 2010; 31(3):213-6. PubMed ID: 21560527
    [No Abstract]   [Full Text] [Related]  

  • 5. Letter to the editor on "Perfluorobutane contrast-enhanced ultrasonography for the diagnosis of HCC: a systematic review and meta-analysis".
    Wu J; Ge L; Lu L
    Abdom Radiol (NY); 2022 Feb; 47(2):903-904. PubMed ID: 34748043
    [No Abstract]   [Full Text] [Related]  

  • 6. The role of contrast-enhanced ultrasound in the detection of focal liver leasions.
    Solbiati L; Tonolini M; Cova L; Goldberg SN
    Eur Radiol; 2001; 11 Suppl 3():E15-26. PubMed ID: 11793049
    [No Abstract]   [Full Text] [Related]  

  • 7. Characterization of focal liver lesions with contrast-specific US modes and a sulfur hexafluoride-filled microbubble contrast agent: diagnostic performance and confidence.
    Quaia E; Calliada F; Bertolotto M; Rossi S; Garioni L; Rosa L; Pozzi-Mucelli R
    Radiology; 2004 Aug; 232(2):420-30. PubMed ID: 15286314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Guidance and control of percutaneous treatments with contrast-enhanced ultrasound.
    Solbiati L; Ierace T; Tonolini M; Cova L
    Eur Radiol; 2003 Nov; 13 Suppl 3():N87-90. PubMed ID: 15015887
    [No Abstract]   [Full Text] [Related]  

  • 9. Sensitivity rates in characterizing hepatocellular carcinomas.
    Caturelli E; Ghittoni G; Roselli P; Anti M
    AJR Am J Roentgenol; 2005 Oct; 185(4):1079-80; author reply 1080-1. PubMed ID: 16177438
    [No Abstract]   [Full Text] [Related]  

  • 10. Emerging clinical applications for contrast-enhanced ultrasonography.
    Spinazzi A
    Eur Radiol; 2001; 11 Suppl 3():E7-12. PubMed ID: 11793047
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of contrast-enhanced ultrasound in the characterisation of focal liver lesions.
    Leen E
    Eur Radiol; 2001; 11 Suppl 3():E27-34. PubMed ID: 11793050
    [No Abstract]   [Full Text] [Related]  

  • 12. Irregular Defects in Hepatocellular Carcinomas During the Kupffer Phase of Contrast-Enhanced Ultrasonography with Perfluorobutane Microbubbles: Pathological Features and Metastatic Recurrence After Surgical Resection.
    Nuta J; Shingaki N; Ida Y; Shimizu R; Hayami S; Ueno M; Fukatsu K; Itonaga M; Yoshida T; Maeda Y; Moribata K; Deguchi H; Maekita T; Iguchi M; Kato J; Yamaue H; Tamai H
    Ultrasound Med Biol; 2017 Sep; 43(9):1829-1836. PubMed ID: 28625558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial.
    Park JH; Park MS; Lee SJ; Jeong WK; Lee JY; Park MJ; Han K; Nam CM; Park SH; Lee KH
    BMC Cancer; 2017 Apr; 17(1):279. PubMed ID: 28420329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kupffer Imaging by Contrast-Enhanced Sonography With Perfluorobutane Microbubbles Is Associated With Outcomes After Radiofrequency Ablation of Hepatocellular Carcinoma.
    Nuta J; Tamai H; Mori Y; Shingaki N; Maeshima S; Shimizu R; Maeda Y; Moribata K; Niwa T; Deguchi H; Inoue I; Maekita T; Iguchi M; Kato J; Ichinose M
    J Ultrasound Med; 2016 Feb; 35(2):359-71. PubMed ID: 26782163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QUIZ HQ 54. Contrast-enhanced ultrasound (CEUS) for the detection and assessment of treatment efficacy in focal liver lesions.
    Gheorghe L; Carabelea A; Vadan R; Becheanu G
    J Gastrointestin Liver Dis; 2009 Dec; 18(4):473-4. PubMed ID: 20076821
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatocellular carcinoma presenting as a wandering abdominal lump with atypical CEUS.
    Xu HS; Li SY; Liang X; Shou JD; Xu K; He YT
    Ultraschall Med; 2013 Aug; 34(4):388-90. PubMed ID: 23929380
    [No Abstract]   [Full Text] [Related]  

  • 17. Hepatocellular carcinoma: spectrum of contrast-enhanced gray-scale harmonic sonography findings.
    Catalano O; Lobianco R; Cusati B; Siani A
    Abdom Imaging; 2004; 29(3):341-7. PubMed ID: 15354343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Contrast-enhanced Ultrasonography with Perflubutane for Determining Histologic Grade in Hepatocellular Carcinoma.
    Tada T; Kumada T; Toyoda H; Ito T; Sone Y; Kaneoka Y; Maeda A; Okuda S; Otobe K; Takahashi K
    Ultrasound Med Biol; 2015 Dec; 41(12):3070-8. PubMed ID: 26360976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contrast-enhanced sonography of a hepatocellular carcinoma undergoing spontaneous necrosis.
    Giannetti A; Corsetti M; Quaranta S; Franci L
    J Clin Ultrasound; 2008 Oct; 36(8):492-6. PubMed ID: 18663752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Reader's letter concerning the article by H. Strunk et al. (Fortschr Röntgenstr 2005, 177:900-904). Erroneous diagnosis of liver metastasis as benign tumor in the contrast media aided "Low-MI-Real-Time" sonography with SonoVue].
    Schlottmann K
    Rofo; 2005 Dec; 177(12):1722-3; author reply 1723. PubMed ID: 16382508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.